NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
0.6003
Dollar change
+0.0003
Percentage change
0.05
%
Index- P/E0.85 EPS (ttm)0.71 Insider Own22.64% Shs Outstand16.77M Perf Week-2.09%
Market Cap10.39M Forward P/E- EPS next Y-0.44 Insider Trans0.00% Shs Float13.38M Perf Month-2.47%
Enterprise Value39.15M PEG- EPS next Q-0.13 Inst Own7.18% Short Float2.42% Perf Quarter-19.96%
Income72.45M P/S5.22 EPS this Y-95.62% Inst Trans1.37% Short Ratio1.99 Perf Half Y-8.50%
Sales1.99M P/B0.54 EPS next Y-344.44% ROA164.24% Short Interest0.32M Perf YTD-4.33%
Book/sh1.12 P/C3.85 EPS next 5Y- ROE- 52W High1.90 -68.41% Perf Year-19.10%
Cash/sh0.16 P/FCF- EPS past 3/5Y- - ROIC147.54% 52W Low0.55 9.15% Perf 3Y-95.58%
Dividend Est.- EV/EBITDA- Sales past 3/5Y81.61% - Gross Margin-89.96% Volatility5.70% 6.46% Perf 5Y-97.99%
Dividend TTM- EV/Sales19.67 EPS Y/Y TTM173.40% Oper. Margin-1801.05% ATR (14)0.04 Perf 10Y-
Dividend Ex-Date- Quick Ratio0.37 Sales Y/Y TTM-33.92% Profit Margin3635.17% RSI (14)42.34 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio0.37 EPS Q/Q112.86% SMA20-3.79% Beta1.07 Target Price11.50
Payout0.00% Debt/Eq0.20 Sales Q/Q-99.21% SMA50-10.09% Rel Volume0.85 Prev Close0.60
Employees39 LT Debt/Eq0.04 EarningsMay 15 BMO SMA200-27.94% Avg Volume162.95K Price0.60
IPOApr 28, 2016 Option/ShortYes / Yes EPS/Sales Surpr.- -20.00% Trades Volume138,599 Change0.05%
Date Action Analyst Rating Change Price Target Change
Mar-30-21Initiated Cantor Fitzgerald Overweight $8
Nov-05-20Initiated Ascendiant Capital Markets Buy $5
Jun-28-18Initiated Maxim Group Buy $5
Jun-24-25 08:01AM
Jun-18-25 12:01PM
Jun-04-25 08:41AM
Jun-03-25 08:31AM
May-27-25 07:31AM
08:01AM Loading…
May-15-25 08:01AM
May-14-25 08:01AM
May-01-25 08:31AM
Apr-30-25 08:31AM
Apr-28-25 12:00PM
Apr-24-25 08:01AM
Apr-11-25 09:23AM
Apr-09-25 07:24PM
04:01PM
Apr-03-25 09:00AM
08:01AM Loading…
Mar-27-25 08:01AM
Mar-25-25 11:08AM
08:01AM
Mar-24-25 08:01AM
Mar-20-25 08:31AM
Mar-18-25 08:31AM
Mar-13-25 07:36AM
Mar-11-25 09:01AM
Mar-10-25 09:01AM
Mar-05-25 04:45PM
Mar-04-25 08:25AM
Feb-27-25 08:31AM
Feb-25-25 08:31AM
Feb-24-25 08:31AM
Feb-20-25 08:31AM
08:30AM Loading…
Feb-18-25 08:30AM
Feb-06-25 08:57AM
Jan-13-25 07:56AM
Dec-23-24 08:01AM
Dec-19-24 08:01AM
Dec-11-24 08:01AM
Dec-03-24 08:01AM
Nov-20-24 07:56AM
Nov-18-24 08:15AM
Nov-14-24 08:01AM
Nov-13-24 08:01AM
Nov-07-24 08:01AM
Nov-05-24 08:01AM
Oct-31-24 08:31AM
Oct-30-24 08:31AM
Oct-15-24 07:51AM
Oct-10-24 07:51AM
Oct-09-24 08:01AM
Oct-08-24 07:49AM
Oct-01-24 08:01AM
Sep-24-24 08:01AM
Sep-16-24 04:30PM
Sep-10-24 07:56AM
Sep-03-24 07:51AM
Aug-20-24 08:16AM
Aug-13-24 08:16AM
08:01AM
Aug-12-24 08:07AM
Aug-08-24 08:31AM
Aug-06-24 08:15AM
Aug-05-24 08:15AM
Jul-30-24 08:15AM
Jul-29-24 08:15AM
Jul-23-24 08:01AM
Jul-11-24 08:31AM
Jul-02-24 07:55AM
Jun-13-24 07:58AM
Jun-12-24 08:05AM
May-14-24 08:21AM
07:53AM
May-13-24 08:43PM
08:00AM
May-09-24 07:49AM
May-07-24 07:39AM
May-03-24 08:35AM
May-02-24 08:35AM
07:49AM
Apr-30-24 07:35AM
Apr-29-24 08:47AM
Apr-10-24 06:15PM
Apr-08-24 08:30AM
Mar-28-24 09:47AM
Mar-27-24 12:35PM
05:52AM
Mar-26-24 07:32PM
Mar-25-24 05:30PM
Mar-21-24 09:30AM
08:30AM
Mar-20-24 08:30AM
Mar-13-24 08:30AM
Mar-12-24 08:30AM
Feb-16-24 05:00PM
Feb-15-24 07:45AM
Feb-08-24 07:45AM
Dec-12-23 08:30AM
Dec-11-23 09:00AM
Dec-05-23 08:55AM
Dec-04-23 04:20PM
Dec-01-23 10:00AM
Nov-20-23 12:44PM
PAVmed, Inc. is a multi-product life sciences company, which engages in the innovation, development, acquisition, and commercialization of products that target unmet medical needs with large addressable market opportunities. Its products include Lucid Diagnostics and Veris Health. The company was founded by Lishan Aklog and Brian J. deGuzman on June 26, 2014 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JAMES L. COXDirectorDec 12 '24Proposed Sale0.789,4697,380Dec 12 05:19 PM
JAMES L. COXDirectorDec 09 '24Proposed Sale0.8638,09532,739Dec 09 05:21 PM
JAMES L. COXDirectorDec 06 '24Proposed Sale1.0015,60015,627Dec 06 05:58 PM
JAMES L. COXDirectorDec 05 '24Proposed Sale1.011,8361,854Dec 05 05:34 PM